 |
 |
 |
 |
 |
 |
|
|
| SPEAKER BIOGRAPHIES
Minister Counsellor Kapalata has held a number of important roles representing her country at the United Nations since 1995, with emphasis on covering the Third Committee (Social, Cultural and Humanitarian Affairs). She has also been responsible for administration and budgetary issues at her Mission. Christine Kapalata’s association with Tanzania’s foreign affairs began in 1980 with her appointment as Third Secretary, Ministry of Foreign Affairs and International Cooperation. In 1983 she was named Second Secretary, and she received promotions to successively more important positions. She pursued her interest in women, children and HIV/AIDS as an advisor or member of a number of Tanzanian Delegations to UN events, most notably the 27th Special Session of the UN General Assembly on Children in 2002 and the General Assembly’s 26th Special Session on the Problem of HIV/AIDS in 2000. She was Chairperson of the Ad Hoc Committee of the Whole for the 23rd Special Session of the United Nations General Assembly entitled “Women 2000: Gender Equality, Development and Peace for the Twenty First Century.” Minister Counsellor Kapalata holds a Bachelor of Arts (Hons.) in International Relations from the University of Dar-es-Salem, Tanzania (1980); an Advanced Diploma in International Relations from the Center for Foreign Relations (1982), Tanzania, and the M.A. in International Relations from the University of Wollongong, Australia.
Heather Lauver is in charge of Global Operations of International Philanthropy Programs at Pfizer Inc, a research-based global health care company that is consistently ranked as one of the top global donors. Ms. Lauver joined Pfizer in 1998 to further develop the International Trachoma Initiative and provide consultation on philanthropy and public health initiatives. She manages focused global giving programs in the areas of health care and community development. Her responsibilities include overseeing all aspects of international humanitarian operations, including strategic planning, budgeting and monitoring and evaluation. Prior to joining Pfizer, Ms. Lauver consulted on and worked in a wide range of US and international healthcare areas, including managed care, substance abuse, physician practice management, process reengineering, international public health, infectious disease management. She also conducted labwork in molecular genetics. Ms. Lauver received her B.A. from Grinnell College (’90), M.P.H. from the Yale University School of Medicine (’95) and M.B.A. from Baruch College (’01). Ms. Lauver serves as Secretary of the Board of the Partnership of Quality Medical Donations (www.pqmd.org) and consults regarding small business initiatives.
Ambassador Moutari has worked in the diplomatic field since 1979. He was Niger's Ambassador to the Soviet Union (1990-1993). Six years later and after holding a number of important positions at the international and national levels, he came to New York as Niger's Ambassador to the United Nations. His previous experiences in Niger include two years as a diplomatic advisor to the Office of the President (1998-1999) and Permanent Secretary at the Ministry of African Integration (1997-1998). He also held posts in Rabat, Morocco, as Special Representative of the Secretary General of the Islamic Conference (1995-1997) and in Jeddah, Saudi Arabia, as Director of Cabinet to the Secretary General of the Islamic Conference. He was Deputy Chief of Mission in Bohn, Federal Republic of Germany (1987-1990), and First Secretary, Permanent Mission of Niger to the United Nations (1979-1982.) Ambassador Moutari received a Bachelor of Arts, International Public Law, and the Maitrise in International Relations from the University of Cameroon, Faculty of Law and Economics, also the Institute Professional Degree from the International Institute for Public Administration in Paris. He was awarded the Master of Public Administration degree from the Robert F. Wagner Graduate School of Public Service at New York University.
Mark Speaker is Vice President, International Government Affairs at Bristol-Myers Squibb Company. He has held this position since 1999. Prior to that, he was Vice President and Associate General Counsel, Nutritional, Health Care and Consumer Groups from 1994-1999; Vice President and Senior Counsel, Mead Johnson & Company from 1992-1994; Counsel, U.S. Pharmaceutical and Nutritional Group from 1990-1992 at Bristol-Myers Squibb Company. From 1986 to 1988, Mr. Speaker worked with the Squibb Corporation as an Associate Litigation Counsel, and Senior Assistant General Counsel, and later Counsel for the Squibb Diagnostics and Apothecon. Mr. Speaker received a B.A. from LaSalle University in 1975, and a J.D. from the University of Virginia in 1978.
Dr. Jeffrey L. Sturchio is Vice President, External Affairs, Human Health – Europe, Middle East & Africa – at Merck & Co., Inc.. He is responsible for the development, coordination, and implementation of a range of health policy and communications initiatives in those regions. He has been centrally involved in Merck’s participation in the UN/Industry Accelerating Access Initiative, which is helping to improve HIV/AIDS care and treatment in the developing world. He is also a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB, and Malaria. Dr. Sturchio received an A.B. in history (1973) from Princeton University and a Ph.D. in the history & sociology of science from the University of Pennsylvania (1981). He has also been a Postdoctoral Fellow and Senior Fellow at the Smithsonian Institution’s National Museum of American History (NMAH). Before he joined Merck in June 1989 as the Company’s first Corporate Archivist he held positions with the AT&T Archives, the Beckman Center for the History of Chemistry at the University of Pennsylvania, Rutgers University, and the New Jersey Institute of Technology. His publications include Chemistry in America, 1876-1986: Historical Indicators (Reidel, 1985; paperback edition, 1988), written with A. Thackray, P.T. Carroll, and R.F. Bud; Values & Visions: A Merck Century (Merck & Co., Inc., 1991); “Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation” (with L. Galambos), Business History Review 72 (Summer 1998): 250-278; “Against: Direct to consumer advertising is medicalising normal human experience” (with S. Bonaccorso), British Medical Journal 324 (13 April 2002): 910-911; and “Successful public private partnerships in global health: lessons from the MECTIZAN Donation Program,” (with B. Colatrella), in The Economics of Essential Medicines, ed. By B. Granville (London: Royal Institute of International Affairs, 2002).
A political scientist and academic since 1967, Dr. Wolfson became a representative of a non-governmental organization at the United Nations in 1991. As a result of her research in the formation of social policy, more than two decades of work on women’s health policy, and her experience at the United Nations, she noted the consistent underattention and inadequate information available about all stages of women’s health throughout the world. She founded the Global Alliance for Women’s Health (GAWH), a non-governmental organization, in 1994 in order to help address these shortcomings through women’s health advocacy, education and promotion internationally. Dr. Wolfson was educated at Smith College (BA) and New York University (MA and Ph.D.) and the Wharton School of the University of Pennsylvania (certificate). She has taught at New York University, the State University of New York, Long Island University, Rutgers University and the City University of New York, and she has held an adjunct appointment at the Columbia University School of Public Health. She has lectured on women’s health at international seminars in Spain, Italy and Korea, and has consulted on women’s health with UNDP and WHO. Her publications on women’s health include articles, monographs and edited compilations. |
|
| Home • Contact Info • Top of Page | ©2004 The Global Alliance for Women's Health |
